INCIDENCE, CLINICAL CHARACTERISTICS, AND RISK FACTORS OF IMMUNE EFFECTOR CELL (IEC) ASSOCIATED HLH-LIKE SYNDROME (IEC-HS) IN PATIENTS TREATED WITH TALICABTAGENE AUTOLEUCEL (HUMANIZED ANTI-CD19 CAR-T)
EHA Library, Hema Hotchandani,
4162553
CAN ONE SCORING SYSTEM FIT ALL? A COMPARATIVE EVALUATION OF CAR-HEMATOTOX, ALL-HT, AND EIPM FOR PREDICTING IMMUNE EFFECTOR CELL-ASSOCIATED HEMATOTOXICITY (ICAHT) AFTER CAR-T IN HEMATOLOGICAL MALIGNANCIES
EHA Library, Ao-ran Zhang,
4162561
REAL-WORLD SICKLE CELL DISEASE PATIENT EXPERIENCE INSIGHTS IN EMERGENCY DEPARTMENT CARE QUALITY: IMPLICATIONS FOR HEALTHCARE INEQUALITIES, REGIONAL VARIATION, AND AI-POWERED SENTIMENT ANALYSIS.
EHA Library, Kim Summers,
4162585
EFFICACY, SAFETY, AND TOLERABILITY OF REGN7999 IN PATIENTS WITH IRON OVERLOAD DUE TO NON-TRANSFUSION-DEPENDENT ß-THALASSEMIA: DESIGN OF THE PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED FERVENT-1 TRIAL
EHA Library, Nikhil Singh,
4162614